Načítá se...
Spotlight on taliglucerase alfa in the treatment of pediatric patients with type 1 Gaucher disease
Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macrophages, resulting in multiple organ dysfunction. There are three commercially available enzyme replacement therapy (ERT) products...
Uloženo v:
| Vydáno v: | Pediatric Health Med Ther |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774592/ https://ncbi.nlm.nih.gov/pubmed/29388611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PHMT.S93634 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|